Report

Vaccine Pricing: Gavi Fully Self Financing and Accelerated Transition Countries

As of November 2018, nine countries are in a state of accelerated transition from Gavi support to self-financing1, and 16 countries have transitioned out of Gavi support2. These countries have requested WHO to provide more visibility on their vaccine purchase price prospects, for both the proper budgeting of ongoing vaccination programs and the introduction of new vaccines.Three manufacturers – GSK, Merck and Pfizer – have committed to continue providing countries that transition out of Gavi support with access to prices similar to those offered to Gavi-supported countries, or to maintain the prices that these countries are currently paying for certain vaccines, for a certain period of time, depending on commitment terms.

These commitments apply to:

• human papillomavirus vaccine (HPV)

• pneumococcal conjugate vaccine (PCV)

• rotavirus vaccine (Rota

Languages

  • English

Publication year

2018

Publisher

WHO

Type

Report

Categories

  • Programme management

Diseases

  • HPV

Organisations

  • WHO

Topic references

EPI-CORE-MI4A

TitleAuthorYearTypeLanguage
Global Market Study: BCG Vaccine - May 2019World Health Organization (WHO)2019ReportEnglish
Global Market Study: Diphtheria and tetanus-containing vaccines - 2019World Health Organization (WHO)2019ReportEnglish
Global Market Study: HPV - 2020World Health Organization (WHO)2020ReportEnglish
Global Market Study: Human Rabies vaccines - 2020World Health Organization (WHO)2020ReportEnglish
Global Market Study: Measles-containing vaccines (MCV) - 2020World Health Organization (WHO)2020ReportEnglish
Global Market Study: Meningococcal meningitis vaccines - 2019World Health Organization (WHO)2019ReportEnglish
Global Market Study: Pneumococcal Conjugate (PCV) and Polysaccharide (PPV) vaccines - 2020World Health Organization (WHO)2020ReportEnglish
Global Market Study: Typhoid vaccines - 2020World Health Organization (WHO)2020ReportEnglish
Global Vaccine Market Report - 2020World Health Organization (WHO)2020ReportEnglish
MI4A Project OverviewWorld Health Organization (WHO)GuidanceEnglish
MI4A Vaccine Purchase Data for Countries - 2022World Health Organization (WHO)DatasheetEnglish
Vaccine Price Report - 2017World Health Organization (WHO)2017ReportEnglish
Vaccine Pricing: Gavi Fully Self Financing and Accelerated Transition CountriesWorld Health Organization (WHO)2018ReportEnglish

PURCHASE_DATA

TitleAuthorYearTypeLanguage
MI4A Vaccine Purchase Data for Countries - 2019World Health Organization (WHO)2019ReportEnglish
MI4A: Vaccine Purchase DataWorld Health Organization (WHO)2019RepositoryEnglish
Vaccine Pricing: Gavi Fully Self Financing and Accelerated Transition CountriesWorld Health Organization (WHO)2018ReportEnglish